Brevan Howard Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
12,870
-12,531
-49% -$252K ﹤0.01% 1818
2025
Q4
$502K Sell
25,401
-4,949
-16% -$88.9K 0.01% 1107
2025
Q3
$530K Sell
30,350
-79,713
-72% -$1.18M ﹤0.01% 1267
2025
Q2
$1.54M Buy
110,063
+36,853
+50% +$593K 0.01% 855
2025
Q1
$1.36M Buy
+73,210
New +$1.09M 0.01% 393
2024
Q4
Sell
-18,109
Closed -$214K 1015
2024
Q3
$214K Buy
+18,109
New +$171K ﹤0.01% 973
2024
Q2
Sell
-19,100
Closed -$94.7K 1038
2024
Q1
$94.7K Buy
+19,100
New +$122K ﹤0.01% 898

Other funds holding ALHC

Brevan Howard Capital Management's ALHC Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Alignment Healthcare (ALHC) stake by 49% in Q1 2026, selling an estimated $252K and leaving 12,870 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Brevan Howard Capital Management first reported a position in ALHC in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.54M in Q2 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Brevan Howard Capital Management held 12,870 shares of Alignment Healthcare worth $227K as of Q1 2026.
  • Brevan Howard Capital Management sold 12,531 Alignment Healthcare shares in Q1 2026, an estimated $252K.
  • Alignment Healthcare made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1818 holding.
  • Brevan Howard Capital Management first reported a position in Alignment Healthcare in Q1 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Alignment Healthcare position peaked at $1.54M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.